title: Identification and treatment of bisphosphonate-associated actinomycotic osteonecrosis of the jaws.
abstract: Osteonecrosis of the jaws (ONJ) is a condition characterized by necrotic exposed bone in the jaws of patients receiving intravenous or oral bisphosphonate therapy. A review of the medical and dental literature reveals that the pathoetiology of ONJ remains unknown and there is no established link that bisphosphonates are the primary cause of this bone pathology. However, there is clinical evidence that Actinomyces may play a critical role in the pathogenesis of bisphosphonate-associated ONJ. Identification and a prolonged course of oral antimicrobial therapy may lead to complete resolution of this actinomycotic osteonecrosis.
authors: CLee555294@aol.com
authors: Cameron Y S
authors: CY
authors: Lee
authors: Francis D
authors: FD
authors: Pien
authors: Jon B
authors: JB
authors: Suzuki
mesh_terms: D000190:Actinomyces / Q000145:classification; D000196:Actinomycosis / Q000175:diagnosis* / Q000188:drug therapy; D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001706:Biopsy; D059266:Bisphosphonate-Associated Osteonecrosis of the Jaw / Q000188:drug therapy / Q000382:microbiology*; D002981:Clindamycin / Q000627:therapeutic use; D015331:Cohort Studies; D003646:Debridement; D004318:Doxycycline / Q000627:therapeutic use; D004917:Erythromycin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006931:Hyperbaric Oxygenation; D008297:Male; D008336:Mandibular Diseases / Q000188:drug therapy / Q000382:microbiology*; D008439:Maxillary Diseases / Q000188:drug therapy / Q000382:microbiology*; D008875:Middle Aged; D010404:Penicillin V / Q000627:therapeutic use; D053657:Platelet-Rich Plasma; D011446:Prospective Studies; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; D002981:Clindamycin; D004917:Erythromycin; D004318:Doxycycline; D010404:Penicillin V